Werewolf Therapeutics Inc. Common Stock (HOWL)
Stock · NASDAQ · Health Care
$0.98as of 10/16/2026
Price chart
Active signals
HOWL Signal Track Record
How signals performed across all stocks →What HOWL's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 42 | -0.6% | 45% | September 16, 2026 |
| Bollinger Band Breakout | 23 | -3.9% | 48% | August 21, 2026 |
| Bollinger Band Breakdown | 19 | -7.8% | 42% | September 29, 2026 |
| 200-Day Moving Average TouchActive now | 7 | -15.7% | 43% | September 2, 2025 |
| Any 20-session window (baseline) | -2.5% | 46% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About HOWL
Werewolf Therapeutics, Inc., a biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. The company designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies through its proprietary PR…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 39
- Website
- werewolftx.com/
Fundamentals
- 1-day range
- $0.8814$0.9219
- Market cap
- $19.58M
- P/E (trailing)
- —
- P/E (forward)
- -1.49
- EPS (trailing)
- $-0.73
- Dividend yield
- —
- Beta
- 0.58
- Avg. volume
- 6.94M
Forecasts
3 analyst ratings
Werewolf Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- HOWLWerewolf Therapeutics Inc. Common Stock$0.98▼ 1.71%Market cap $19.58MP/E —$0.27$2.24
- RKTORocket One Inc. Common Stock$0.507▼ 5.59%Market cap $19.75MP/E —$0.51$2.45
- CELUCelularity Inc. Class A Common Stock$1.25▼ 6.02%Market cap $19.77MP/E —$0.5601$2.55
- GRDXGridAI Technologies Corp. Common Stock$4.22▼ 5.38%Market cap $19.91MP/E —$1.87$6.93
- DAREDare Bioscience Inc. Common Stock$0.725▼ 2.03%Market cap $19.92MP/E —$0.69$3.78
- CLRBCellectar Biosciences Inc. Common Stock$1.14▼ 4.20%Market cap $20.14MP/E —$1.15$5.07
- NRSNNeuroSense Therapeutics Ltd. Ordinary Shares$3.07▼ 3.15%Market cap $19.00MP/E —$3.05$26.64
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| HOWL Werewolf Therapeutics Inc. Common Stock | $19.58M | — | $0.98 | ▼ 1.71% | $0.27$2.24 |
| RKTO Rocket One Inc. Common Stock | $19.75M | — | $0.507 | ▼ 5.59% | $0.51$2.45 |
| CELU Celularity Inc. Class A Common Stock | $19.77M | — | $1.25 | ▼ 6.02% | $0.5601$2.55 |
| GRDX GridAI Technologies Corp. Common Stock | $19.91M | — | $4.22 | ▼ 5.38% | $1.87$6.93 |
| DARE Dare Bioscience Inc. Common Stock | $19.92M | — | $0.725 | ▼ 2.03% | $0.69$3.78 |
| CLRB Cellectar Biosciences Inc. Common Stock | $20.14M | — | $1.14 | ▼ 4.20% | $1.15$5.07 |
| NRSN NeuroSense Therapeutics Ltd. Ordinary Shares | $19.00M | — | $3.07 | ▼ 3.15% | $3.05$26.64 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →- Luke Evnin · July 7, 2026 · Sale107.4K @ $0.31
- Luke Evnin · July 6, 2026 · Sale35.8K @ $0.32
- RA Capital Healthcare Fund LP · June 17, 2026 · Sale27.7K @ $0.35
- RA Capital Healthcare Fund LP · June 17, 2026 · Sale389.2K @ $0.35
- RA Capital Healthcare Fund LP · June 16, 2026 · Sale9.9K @ $0.37
- RA Capital Healthcare Fund LP · June 16, 2026 · Sale139.7K @ $0.37
- RA Capital Healthcare Fund LP · June 15, 2026 · Sale8.6K @ $0.39
- RA Capital Healthcare Fund LP · June 15, 2026 · Sale120.2K @ $0.39
- RA Capital Healthcare Fund LP · June 12, 2026 · Sale11.3K @ $0.4
- RA Capital Healthcare Fund LP · June 12, 2026 · Sale159.1K @ $0.4
- RA Capital Healthcare Fund LP · June 11, 2026 · Sale17.4K @ $0.38
- RA Capital Healthcare Fund LP · June 11, 2026 · Sale245.1K @ $0.38
- RA Capital Healthcare Fund LP · June 10, 2026 · Sale3.1K @ $0.37
- RA Capital Healthcare Fund LP · June 10, 2026 · Sale42.9K @ $0.37
- RA Capital Healthcare Fund LP · June 9, 2026 · Sale24.6K @ $0.37
Institutional Ownership
March 31, 2026
- Total shares held
- 13.83M
- Total value held
- $11.50M
- Institutional holders
- 45
- Unknown6.68M
- Unknown1.22M
- Unknown1.21M
- Unknown657.8K
- Unknown626.8K
- Unknown589.1K
- Unknown563.5K
- Unknown516.2K
- Unknown389.5K
- Unknown264.6K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
No Relevant News for HOWL in Last Week
The only news item in the last week concerns HALO's expanded collaboration with ARGX. This development does not involve Werewolf Therapeutics, so it has no direct impact on HOWL's operations or outlook. Investors may focus on the company's own pipeline and financials for guidance.
No Relevant News for HOWL in Last Week. The only news item in the last week concerns HALO's expanded collaboration with ARGX. This development does not involve Werewolf Therapeutics, so it has no direct impact on HOWL's operations or outlook. Investors may focus on the company's own pipeline and financials for guidance.